Botox Side Effects: Expected, Uncommon, and the Ones That Matter

The expected effects nobody warns you about

A large share of what patients report as a "side effect" is simply what a needle does to skin. Small bruises at the injection points are common, particularly around the eyes where the skin is thin and the vessels are superficial. Redness and small raised bumps appear immediately and settle within fifteen to thirty minutes. Tenderness where the needle went in can last a day or two.

A mild headache in the first forty-eight hours is also frequent, especially after treatment of the forehead and glabella. It is usually described as a dull pressure rather than a migraine, and it passes. Paradoxically, botulinum toxin is also used therapeutically in chronic migraine, so a short-lived headache after a cosmetic session is not a sign that something went wrong.

What separates these from complications is that they are self-limiting and predictable. A clinic that presents them as unexpected is either inexperienced or managing your expectations badly. You should be told about them before the needle, not after the bruise. Our main Botox page covers what a proper consultation includes.

Droop: the side effect that actually matters

The one that changes how a face looks is ptosis — a droop. It has two distinct versions, and they are often confused.

Eyelid ptosis happens when toxin injected near the glabella diffuses down through the orbital septum and reaches the muscle that lifts the upper lid. The eyelid sits lower on one or both sides. It is the least common of the two and the most distressing, because it is visible in every photograph.

Brow ptosis — a heavy, flattened brow — is more frequent and is usually a dosing decision rather than an accident. The frontalis is the only muscle that lifts the brow. Relax too much of it, particularly in its lower fibres or in a patient who unconsciously uses it to hold the brows up, and the brow settles downward. The forehead looks smooth and the eyes look tired.

Both are temporary, and that word deserves qualification: temporary means weeks. Eyelid ptosis commonly improves within three to six weeks as the affected fibres recover, and prescription eye drops can partially lift the lid in the meantime. It is not something you wait out over a weekend, which is exactly why conservative dosing at a first treatment is worth more than a dramatic result. Our guide on lower-dose treatment explains that trade-off.

Asymmetry, frozen looks and the raised outer brow

Asymmetry is common and usually correctable. Faces are not symmetrical to begin with, muscle strength differs between sides, and the toxin does not spread identically. Most asymmetry is noticed at the two-week mark and resolved by adding a few units to the stronger side. This is precisely why a two-week review exists, and why a clinic that offers no review is not offering complete treatment.

The raised, peaked outer brow — sometimes called a Spock brow — occurs when the central forehead is relaxed but the outer fibres are left active, so they pull the tail of the brow upward without opposition. It looks surprised or severe. A few units at the outer frontalis usually settles it, again at the review.

The frozen look is not a complication in the medical sense. It is a dosing choice that did not match what the patient wanted. It matters because it is the single most common reason people say they will never do it again — and the fix is a conversation before treatment about how much movement you want to keep, not a different product.

The uncommon and the serious

Around the eyes, diffusion into the muscles that move the eyeball can cause double vision or difficulty focusing. It is uncommon and temporary, and it warrants contacting the treating physician rather than waiting.

Treatment near the mouth or jaw can affect the muscles of the smile, producing an uneven or weakened expression, and in masseter treatment some patients notice temporary chewing fatigue. Around the neck, higher doses have been associated with difficulty swallowing.

Beyond that sits the reason botulinum toxin products carry a regulatory boxed warning: the effect can, rarely, spread beyond the injection site, producing symptoms of botulism such as generalised muscle weakness, drooping across the face, blurred or double vision, hoarseness, trouble speaking, or difficulty swallowing or breathing. These reports are associated far more with high therapeutic doses in children treated for spasticity than with cosmetic dosing in adults — but the warning exists on the label and any honest article about side effects has to name it.

What to do with that information is straightforward rather than frightening: know the symptoms, know that they can appear hours to weeks after treatment, and treat difficulty swallowing or breathing as an emergency rather than something to discuss at your review. Serious allergic reactions are rare but follow the same rule.

Can Botox be reversed? The honest answer is no

This is the question patients most often ask after an unwanted result, and the answer is unambiguous: there is no antidote for botulinum toxin. It is worth understanding why, because the confusion comes from a real difference between injectables.

Hyaluronic acid filler can be dissolved. An enzyme, hyaluronidase, breaks it down, and a bad filler result can be substantially undone in a single appointment. That reversibility is one of the genuine advantages of hyaluronic acid over other materials, and we cover it in our comparison of filler brands and how to verify them.

Botulinum toxin works differently. It binds at the nerve ending and blocks the chemical signal that tells the muscle to contract. Nothing unbinds it. Function returns only as the nerve grows new terminals — a biological process that takes its own time, typically three to four months at standard cosmetic dosing, and less at lower doses.

What can be done in the meantime is limited but real. Eye drops can lift a drooping lid partially. Adding small amounts to an opposing muscle can rebalance an asymmetry, which is a camouflage rather than a reversal. Beyond that, the treatment is patience. That asymmetry between the two injectables is the single most practical reason to be conservative with toxin at a first session, and it is why we would rather underdose and top up than the reverse. Our detailed guide on what to do when a result goes wrong sets out the sequence.

"I had Botox and I see no result"

Before concluding that a product failed, check the calendar. Onset is not immediate: movement begins to soften around day three to five, and the full effect arrives at ten to fourteen days. Judging at day four is the most common reason patients believe nothing happened.

If you are genuinely at two weeks with no change, the likely explanations, in order of frequency, are these. The dose was too low for your muscle — strong glabellar muscles, common in men, need more units than a standard chart suggests. The wrong muscle was targeted, or the injection was too superficial or too far from the motor point. The product was mishandled: botulinum toxin is a protein, and incorrect reconstitution, storage or dilution degrades it. And in a small minority, antibodies to the toxin reduce or abolish the response — more likely in people treated frequently with large doses over years, which is one argument against short intervals between sessions.

The practical step is a review with the injector rather than a second treatment somewhere else. Adding units at two weeks is straightforward. Starting a fresh course elsewhere without knowing what was used, at what dose and where, discards the only useful information you have. If duration rather than onset is the concern, how long results last covers the variables.

Who should not have it, and who should not inject it

Botulinum toxin is avoided in pregnancy and breastfeeding — not because harm is established, but because it has not been studied in those groups and there is no reason to accept an unknown for an elective treatment. It is also avoided in people with neuromuscular disorders such as myasthenia gravis, Lambert-Eaton syndrome or motor neurone disease, where blocking neuromuscular transmission carries real risk, and in anyone with an active infection at the injection site or a known hypersensitivity to any component.

Certain medications, particularly some antibiotics that themselves interfere with neuromuscular transmission, can amplify the effect. This is one of several reasons a proper history is taken before a first treatment rather than a form being signed at the door.

The other half of the question is who holds the syringe. Most avoidable side effects are anatomical: too much product, in the wrong plane, too close to a muscle that should have been left alone. That is a knowledge problem, not a product problem, and it is why who injects you changes your risk more than which brand is used. At HealthBridge, treatment is applied by a licensed physician under Colombian regulations after an individualized assessment, coordinated by Dra. Olga González, whose practice is in aesthetic and regenerative medicine. Verifying the licence of whoever treats you — anywhere in the world — is a reasonable thing to ask and an easy thing to check.

How to lower your own risk

Very little of the outcome is in the patient's hands, but the part that is matters. Say what you want in terms of movement, not in units or in the name of a technique: "I want to keep being able to raise my brows" gives an injector far more to work with than a dose request copied from social media.

Report your history honestly, including previous treatments, how you responded and any medication. If a previous result was too heavy, saying so lets the injector plan around it.

Book the two-week review before you leave, and keep it even if you are happy. It is where asymmetries are corrected while correction is still easy, and for international patients it is the appointment most often skipped for the sake of a flight. If your trip is short, ask how the review will be handled remotely before you agree to treatment.

Finally, be sceptical of price as the deciding factor. Toxin has a real cost per unit, and a quote far below the local market is being financed somewhere — usually in dilution, in who injects, or in the absence of any follow-up. Our price guide by area sets out what the numbers actually cover.